C
CELC
Celcuity Inc
67.94
+0.07+0.10%After Hours: 67.94 0.00 0.00%19:39 10/09 EDT
OPEN/PREV CLOSE67.78/67.87
TODAY RANGE66.91-68.53
VOL1.28M
MARKET CAP3.32B
52 WEEK RANGE45.03-151.02
AVG VOL (3M)1.25M
% TURNOVER2.30%
TURNOVER--
P/E (TTM)-15.8107
% RANGE2.39%
EPS(TTM)-4.2971
P/E(FORWARD)-13.3289
P/B-260.0077
BVPS-0.2613
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.77B
SHARES OUTSTANDING48.93M
NEXT EARNINGS11/10-11/16
FREE FLOAT40.73M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·6d ago
Most shorted stocks on Wall Street
TipRanks·10/02 12:28
Celcuity adds seasoned director amid oncology commercialization push
TipRanks·10/02 12:05
Celcuity appoints Gryska to Board of Directors
Dow Jones·10/02 12:00
*Celcuity Appoints David Gryska to Its Bd of Directors
Dow Jones·10/02 12:00
Press Release: Celcuity Appoints David Gryska To Its Board Of Directors
TipRanks·10/01 14:45
Celcuity (CELC) Gets a Buy from H.C. Wainwright
TipRanks·10/01 13:25
Leerink Partners Reaffirms Their Buy Rating on Celcuity (CELC)
Dow Jones·09/30 15:41
Celcuity Is Maintained at Buy by Needham
Dow Jones·09/30 15:41
Celcuity Price Target Cut to $134.00/Share From $140.00 by Needham
Benzinga·09/30 15:32
Needham Maintains Buy on Celcuity, Lowers Price Target to $134
TipRanks·09/30 12:32
Celcuity launches REVTORPYK for advanced breast cancer
TipRanks·09/30 12:16
Celcuity announces REVTORPYK is now commercially available in U.S.
Seeking Alpha·09/18 09:20
Faeth Therapeutics: 'Buy' PIKTOR EC Data Year-End 2026 And HR+/HER2- BC Drug Expansion
Dow Jones·09/17 12:12
Celcuity Initiated at Overweight by JP Morgan